Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 27, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 117,296	$ 131,913
Restricted cash, current	1,170	1,041
Accounts receivable, net	27,920	26,862
Inventory	110,294	113,444
Prepaid expenses and other current assets	31,048	11,332
Assets held for sale	910	1,864
Total current assets	288,638	286,456
Restricted cash, non-current	12,600	12,600
Property, plant and equipment, net	254,387	184,887
Operating lease right-of-use assets	5,218	123,975
Prepaid lease costs, non-current	35,704	68,005
Other non-current assets, net	1,599	622
Investment in unconsolidated joint venture	1,523	1,601
Total assets	599,669	678,146
Current liabilities:
Accounts payable	46,091	37,571
Current portion of operating lease liabilities	1,753	4,125
Accrued expenses and other current liabilities	11,244	11,656
Accrued litigation settlement	0	7,250
Short-term finance lease liabilities	4,554	851
Total current liabilities	63,642	61,453
Long-term liabilities:
2027 notes, net	1,144,427	1,141,476
Delayed draw term loans, net	77,734	0
Delayed draw term loan warrants	14,825	0
Operating lease liabilities, net of current portion	4,023	73,613
Finance lease obligations and other long-term liabilities	79,083	2,812
Total long-term liabilities	1,320,092	1,217,901
Commitments and contingencies (Note 10)
Stockholders’ deficit:
Preferred stock, par value $0.0001 per share—500,000 shares authorized, none issued and outstanding	0	0
Common stock, par value $0.0001 per share—500,000,000 shares authorized; 76,751,920 shares and 76,065,969 shares issued and outstanding at September 27, 2025 and December 31, 2024, respectively	8	8
Additional paid-in capital	657,549	644,004
Accumulated deficit	(1,434,377)	(1,241,531)
Accumulated other comprehensive loss	(7,245)	(3,689)
Total stockholders’ deficit	(784,065)	(601,208)
Total liabilities and stockholders’ deficit	$ 599,669	$ 678,146